J Rodríguez

ORCID: 0000-0001-6289-3658
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac pacing and defibrillation studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Advanced MRI Techniques and Applications
  • Cardiomyopathy and Myosin Studies
  • Cardiac Imaging and Diagnostics
  • Cardiovascular Function and Risk Factors
  • Quality and Management Systems
  • Cardiac Valve Diseases and Treatments
  • MicroRNA in disease regulation
  • Atrial Fibrillation Management and Outcomes
  • Pharmacovigilance and Adverse Drug Reactions
  • Circular RNAs in diseases
  • Renal cell carcinoma treatment
  • Mechanical Circulatory Support Devices
  • Multiple and Secondary Primary Cancers
  • Adipokines, Inflammation, and Metabolic Diseases
  • Renal Diseases and Glomerulopathies
  • Extracellular vesicles in disease
  • Sympathectomy and Hyperhidrosis Treatments
  • Coronary Interventions and Diagnostics
  • Trypanosoma species research and implications
  • Healthcare Systems and Public Health
  • Eicosanoids and Hypertension Pharmacology
  • Pharmaceutical studies and practices
  • Atherosclerosis and Cardiovascular Diseases

Hospital Clínic de Barcelona
2018-2025

Escuela Superior Politécnica del Chimborazo
2023

The objective of this study was to assess the effect that triple therapy (anticoagulation plus CS plasma exchange and/or IVIGs) has on mortality risk patients with catastrophic APS (CAPS) included in CAPS Registry.Patients from Registry were grouped based their treatments: therapy; drugs but different combinations; and none treatments therapy. primary endpoint all-cause mortality. Multivariate logistic regression models used compare between groups.The cohort 525 episodes accounting for 502...

10.1093/rheumatology/key082 article EN Lara D. Veeken 2018-03-09

Circulating extracellular vesicles (EVs) have a great impact on human health as biomarkers and messengers in intercellular signalling. We aimed to determine how the miRNA profile of circulating EVs during an acute coronary event interferes with vasculogenic potential endothelial cells (EC). were purified from plasma patients phase non-ST segment elevation myocardial infarction (NSTEMI, n = 33) healthy donors (n 19) used control group. Human ECs treated EV suspension (5 × 107 particles/cm2)...

10.1111/eci.70022 article EN European Journal of Clinical Investigation 2025-03-06

A documentary review was carried out on the production and publication of research papers related to study variables Legal Standards Sustainable Manufacturing. The purpose bibliometric analysis proposed in this document know main characteristics volume publications registered Scopus database during period 2018-2022, achieving identification 107 publications. information provided by platform organized through graphs figures categorizing Year Publication, Country Origin, Area Knowledge Type...

10.59670/jns.v33i.901 article EN Journal of Namibian Studies History Politics Culture 2023-05-21

Abstract Background Left ventricular ejection fraction (LVEF) has traditionally been used as the cornerstone for risk stratification after STEMI and it can be accurately quantified by cine cardiovascular magnetic resonance (CMR). In recent years, additional prognostic value of contrast CMR-derived infarct size (IS) microvascular obstruction (MVO) soon infarction demonstrated. The usefulness LVEF in chronic phase late is unclear. Purpose We hypothesized that 6-month contribute prediction...

10.1093/eurheartj/ehz746.0993 article EN European Heart Journal 2019-10-01

Abstract Introduction Cardiac magnetic resonance (CMR) has emerged as the most potent non-invasive imaging technique for risk stratification after ST-segment elevation myocardial infarction (STEMI) but an indiscriminate use in all patients is unfeasible. Echocardiography (Echo) been universally used prognostication this scenario. We hypothesized that left ventricular ejection fraction (LVEF) by Echo can represent gatekeeper selecting those who benefit from CMR prognostic purposes. Methods...

10.1093/eurheartj/ehz748.0240 article EN European Heart Journal 2019-10-01
Coming Soon ...